GT Biopharma Inc (LTS:0RU9)
€ 1147194 0 (0%) Market Cap: 5.92 Mil Enterprise Value: -3.33 Mil PE Ratio: 0 PB Ratio: 2.99 GF Score: 34/100

GT Biopharma Inc to Discuss Management Update Call Transcript

Nov 30, 2021 / 09:30PM GMT
Release Date Price: €1147194
Operator

Greetings. Welcome to the GT Biopharma corporate update conference call. (Operator Instructions) Please note this conference is being recorded. I will now turn the conference over to your host, Corey Davis. You may begin.

Corey Davis
LifeSci Advisors - IR

Thanks, operator. Before we begin, I'd like to remind everyone that statements made during this conference call relating to GT Biopharma's expected future performance, future business prospects, or future events or plans may include forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995. All such forward-looking statements are intended to be subject to the Safe Harbor protection provided by the Reform Act. Actual outcomes and results could differ materially from these forecasts due to the impact of many factors beyond the control of GT Biopharma.

GTB expressly disclaims any duty to provide updates to its forward-looking statements, whether as a result of new information, future events, or otherwise. Participants are directed to examine the factors that could

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot